Table 3.
Comparison of model results with other studies.
| CANO, ppb | J′awNO, pl/s | Reference | |
|---|---|---|---|
| Adult control | 1.77 (0.51–3.10) | 1199 (455–3295) | this study |
| Pediatric controls | 4.14 (0.89–6.97) | 725 (173–3470) | |
| Ped. Allergic Rhinitis | 3.50 (0.46–19.1) | 1140 (52 – 4444) | |
| Ped. Intermittent/Mild Asthma | 4.85 (0.26–11.5) | 1223 (105–3996) | |
| Ped. Moderate/Severe Asthma | 3.80 (0.51–12.0) | 2210 (464–6364) | |
| Ped. Asthma Exacerbation | 5.45 (0.21–8.17) | 1699 (80–4269) | |
| Ped. Asthma Post-exacerbation | 4.44 (2.02–8.15) | 1229 (132–3807) | |
| Adult Asthma Exacerbation | 2.64 (0.25–5.67) | 1330 (336–6076) | |
| Adult Asthma Post-exacerbation | 4.98 (0.57–38.1) | 651 (87–2854) | |
| COPD Exacerbation | 4.77 (0.34–14.1) | 1062 (219–3068) | |
| COPD Post-Exacerbation | 5.95 (0.16–17.9) | 1353 (309–3955) | |
| Adult controls | 0.66 ± 0.98 | 770 ± 470 | Condorelli[28] |
| Controls, Adults | 2.2 ± 1.5 | Kerckx[34] | |
| Asthmatics, Adults | 1.5 ± 1.8 | ||
| FENO≤350 | |||
| FENO>50 | 2.1 ± 3.3 | ||
| Normal, Peds. | 1.63 (0.44 – 3) | 480 (196 – 1913) | Paraskakis[33] |
| Asthmatics, Peds. | 2.22 (0.44 – 6.6) | 1230 (204 –9236) | |
| Nonasthmatic, atopic, Peds. | 1.21 (0.03 – 2.85) | 1225 (486 – 4119) | |
| Non asthmatic non-atopic controls, Peds. | 1.5 (0.1 – 2.2) | 700 (100 – 1400) | Puckett[32] |
| ICS-treated asthma, Peds. | 1 (0.006 – 5.1) | 1100 (100 – 14000) | |
| ICS naïve asthma, Peds. | 1.5 (0.02 – 13.4) | 2800 (200 – 17000) |